Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert H Glassman

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Clinical Advances in Hematology & Oncology : H&O|August 4, 2007
Wall Street's perspective on oncology drug developmentRobert H Glassman
Nature Reviews. Drug Discovery|March 26, 2004
Biotechnology: identifying advances from the hypeRobert H Glassman, Anthony Y Sun
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 2007
Biomarkers in phase I oncology trials: signal, noise, or expensive distraction?Mark J Ratain, Robert H Glassman
Nature Reviews. Clinical Oncology|August 30, 2020
When are results of single-arm studies dramatic?Robert H Glassman, Grace Kim, Marc J Kahn
Therapeutic Advances in Respiratory Disease|September 3, 2020
Doxycycline treatment of high-risk COVID-19-positive patients with comorbid pulmonary diseasePaul A Yates, Steven A Newman, Lauren J Oshry, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Clinical Advances in Hematology & Oncology : H&O|August 4, 2007
Wall Street's perspective on oncology drug developmentRobert H Glassman
Nature Reviews. Drug Discovery|March 26, 2004
Biotechnology: identifying advances from the hypeRobert H Glassman, Anthony Y Sun
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 2007
Biomarkers in phase I oncology trials: signal, noise, or expensive distraction?Mark J Ratain, Robert H Glassman
Nature Reviews. Clinical Oncology|August 30, 2020
When are results of single-arm studies dramatic?Robert H Glassman, Grace Kim, Marc J Kahn
Therapeutic Advances in Respiratory Disease|September 3, 2020
Doxycycline treatment of high-risk COVID-19-positive patients with comorbid pulmonary diseasePaul A Yates, Steven A Newman, Lauren J Oshry, et al.
Pageof 1